
Please try another search
Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. Its genome editing toolbox includes nuclease-based genome editing, base editors, RNA-mediated integration, including prime editing, and DNA-mediated integration, such CRISPR-associated transposases. The company has a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop and commercialize investigational medicines using genome editing technologies; and a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited TCR-based therapeutic products exclusively in the field of treatment, prevention, or diagnosis of any human cancer. Metagenomi, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.
Name | Age | Since | Title |
---|---|---|---|
Brian Charles Thomas | 55 | 2016 | Co-Founder, CEO & Chairman of the Board |
Jian Irish | 60 | 2021 | President, COO & Director |
Joseph Knowles | - | - | Co-Founder & Member of Scientific Advisory Board |
Juergen Eckhardt | 57 | - | Independent Director |
Aude G. Chapuis | - | - | Member of Scientific Advisory Board |
Willard H. Dere | 71 | 2021 | Lead Independent Director |
Philip D. Greenberg | - | - | Member of Scientific Advisory Board |
Thomas Schmitt | - | - | Member of Scientific Advisory Board |
Chad A. Cowan | 53 | - | Member of Scientific Advisory Board |
Eric H. Bjerkholt | 65 | 2025 | Independent Director |
Laurence E. Reid | 61 | 2025 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review